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Acute respiratory distress syndrome (ARDS) is a pulmonary disorder associated with alterations to the
pulmonary surfactant system. Recent studies showed that supra-physiological levels of cholesterol in
surfactant contribute to impaired function. Since cholesterol is incorporated into surfactant within the
alveolar type II cells which derives its cholesterol from serum, it was hypothesized that serum hy-
percholesterolemia would predispose the host to the development of lung injury due to alterations of
cholesterol content in the surfactant system.
Wistar rats were randomized to a standard lab diet or a high cholesterol diet for 17–20 days. Animals
were then exposed to one of three models of lung injury: i) acid aspiration ii) ventilation induced lung
injury, and iii) surfactant depletion. Following physiological monitoring, lungs were lavaged to obtain
and analyze the surfactant system.
The physiological results showed there was no effect of the high cholesterol diet on the severity of
lung injury in any of the three models of injury. There was also no effect of the diet on surfactant
cholesterol composition. Rats fed a high cholesterol diet had a signiﬁcant impairment in surface tension
reducing capabilities of isolated surfactant compared to those fed a standard diet exposed to the sur-
factant depletion injury. In addition, only rats that were exposed to ventilation induced lung injury had
elevated levels of surfactant associated cholesterol compared to non-injured rats.
It is concluded that serum hypercholesterolemia does not predispose rats to altered surfactant
cholesterol composition or to lung injury. Elevated cholesterol within surfactant may be a marker for
ventilation induced lung damage.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Acute Respiratory Distress Syndrome (ARDS) is a pul-
monary disorder caused by one or multiple insults to the lung and
is characterized by severe hypoxemia (PaO2:FiO2o200 mmHg)
with radiographic bilateral lung inﬁltrates [1]. ARDS carries a
mortality rate of approximately 40% and in lieu of effective phar-
macological therapies, the mainstay of treatment remains sup-
portive through the use of low tidal volume mechanical ventilation
to maintain adequate arterial oxygenation [2,3]. The pathophy-
siology of ARDS is complex and involves multiple contributing
factors including lung edema formation, maladaptive inﬂamma-
tion, and alterations to the pulmonary surfactant system [4,5].B.V. This is an open access article u
stitute, Western University,
ada N6A 4V2.
zen).
his manuscript.Even prior to the development of ARDS, it has been suggested that
certain individuals may be at an increased risk for the suscept-
ibility to disease, and the development of poorer outcomes. An
example of such susceptibility is chronic alcohol intake, which
may be related to an increased vulnerability to some of these
pathogenic mechanisms described above [6].
Among the various pathophysiological processes occurring in
ARDS, alterations and dysfunction of the pulmonary surfactant
system has been consistently observed across all causes. Dys-
functional surfactant not only contributes directly to altered lung
physiology but also impacts local inﬂammatory responses [5,7,8].
Pulmonary surfactant is a lipoprotein complex synthesized and
secreted by alveolar type II cells into the alveolar space where it
reduces the work of breathing by stabilizing the lung through
reducing the surface tension, especially during low lung volumes
[9,10]. Obtained from bronchoalveolar lavage material, two ex-
tracellular surfactant subtypes can be isolated; the surface active
large aggregates (LA) and the inactive small aggregates (SA) [11].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tral lipids (3–10%) – the majority of which is cholesterol, and sur-
factant associated proteins (5–10%). The precise balance of sur-
factant's constituent components is paramount to the material's
biophysical properties and changes to the composition can impair
surfactant's ability to function [10,12].
In the setting of ARDS, numerous studies have demonstrated
profound alterations to the surfactant phospholipid species com-
position, surfactant proteins levels, and decreased levels of the LA
surfactant subtype [5,7,8]. These changes, together with biophy-
sical inhibition by serum proteins that have leaked into the lung,
have traditionally thought to be the primary contributors to sur-
factant dysfunction [12–14]. Interestingly, recent in vitro biophy-
sical studies and experiments with animal models of lung injury
have demonstrated that elevated cholesterol within surfactant
represents a distinct mechanism of surfactant dysfunction [15–17].
For example our group has previously shown that in a rat model of
ventilator-induced lung injury (VILI) there was increased surfac-
tant associated cholesterol in LA, contributing directly to surfac-
tant's biophysical dysfunction. Furthermore, a reduction of cho-
lesterol to baseline physiological levels could restore isolated
surfactants innate biophysical function [17]. The mechanisms by
which cholesterol content within surfactant increases in the set-
ting of ARDS are unknown. It has been shown that under normal
physiological conditions the majority of cholesterol found within
surfactant is derived by uptake from the circulation [18,19], with
subsequent intracellular regulation of this cholesterol to allow for
the incorporation into surfactant [20,21]. It was therefore hy-
pothesized that serum hypercholesterolemia would predispose
the host to the development of severe lung injury due to changes
to the cholesterol content within pulmonary surfactant. In order to
test this hypothesis rats fed a standard and high cholesterol diet
were subjected to three independent experimental models of lung
injury.2. Materials and methods
2.1. Animal procedures
Eighty-six 6-week old male Wistar rats (Charles River, St.
Constant, Quebec, Canada) were used for these experiments. All
procedures were approved by the Animal Care Committee at
Western University and are in agreement with the guidelines of
the Canadian Council of Animal Care. Animals were acclimatized
for three days and had ad libitum access to water and a standard
laboratory diet. Following acclimatization, animals were rando-
mized to either a standard or a high-cholesterol diet (0.5% cholic
acid and 1.25% cholesterol by mass; Harlan Teklad, Madison, WI,
USA) and allowed food ad libitum. Rats were fed their respectiveTable 1
Baseline characteristics of non-injured rats fed a standard or high cholesterol diet for 1
Baseline characteristics
Weight (g)
Serum analysis Cholesterol (mmol/L)
High density lipoprotein (mmol/L)
Triglycerides (mmol/L)
Lavage analysis Total surfactant (mg/kg BW)
Large aggregates (LA) (mg/kg BW)
Small aggregates (SA) (mg/kg BW)
% LA (% of total surfactant)
Cholesterol (% of LA)
Protein content (mg/kg weight)
* Po0.05 Standard versus high cholesterol diet.diet for 17–20 days. Animals were subsequently exposed to one of
three different models of experimental lung injury: 1) acid as-
piration, 2) high-tidal volume mechanical ventilation, or 3) whole-
lung lavage. In order to obtain non-injured controls, 5–6 animals
from each diet group were euthanized by intraperitoneal sodium
pentobarbital overdose (110 mg/kg) for determination of baseline
serum cholesterol levels and lung lavage analysis as described
below. High density lipoprotein (HDL) and triglycerides levels in
serum were determined via enzymatic colorimetric assays by
London Laboratory Services Group (London On).
At the outset of each experimental model of lung injury, sur-
gical procedures were utilized for anesthesia and instrumentation
as previously reported by Maruscak et. al [22]. Brieﬂy, animals
were anesthetized via intraperitoneal injection of 75 mg/mL ke-
tamine and 5 mg/mL xylazine in sterile saline. After appropriate
sedation, animals were given a subcutaneous injection of 0.1 mg/
kg buprenorphine and a 0.2 mL subcutaneous injection of a 0.5%
local anesthetic sensorcaine at the ventral neck area. After ex-
posure of the ventral neck area, the left and right jugular veins and
the right carotid artery were exposed and catheterized with PE-50
tubing. The left jugular catheter was used to deliver anesthetic/
analgesic (0.5–2.5 mg/100 g/h propofol) and the right jugular ca-
theter was used to continuously deliver ﬂuid (sterile saline with
100 IU heparin/L at 0.5–1.0 mg/100 g/h). The carotid artery cathe-
ter was used to measure blood pressure, heart rate, collect blood
for blood gas measurements (ABL 500 Radiometer, Copenhagen,
DK), and continuously deliver ﬂuids (sterile saline with 100 IU
heparin/L at 0.5–1.0 mg/100 g/h). All ﬂuids and anesthetics were
delivered via infusion pumps (Harvard Instruments, St. Laurent,
QC, Canada). After exposure of the trachea, a 14-gauge en-
dotracheal tube was inserted and ﬁrmly secured.
Following these surgical preparations, animals were given a
0.1 mL IV bolus of 2 mg/mL neuromuscular inhibitor pancuronium
bromide and then immediately connected to a volume-cycled ro-
dent ventilator (Harvard Instruments, St. Laurent, Quebec, Canada)
via endotracheal tube. The ventilator was set to initially deliver:
8 mL/kg tidal volume (Vt), respiratory rate (RR) of 54–58 breaths
per minute (bpm), 5 cmH2O positive end-expiratory pressure
(PEEP), and a fraction of inspired oxygen (FiO2) of 1.0. Animals
were ventilated for ﬁfteen minutes prior to initial baseline blood-
gas measurements. To ensure animals did not have pre-existing
lung injury, the baseline (BL) inclusion criteria following this
procedure was PaO2/FiO2Z400 mmHg.
2.2. Experimental models of lung injury
2.2.1. Acid aspiration
A model of acid-aspiration injury was utilized as described pre-
viously [23]. Following the initial surgical procedure, rats meeting the
BL inclusion criteria were randomized to receive an intra-tracheal7–20 days.
Standard diet (n¼6) High cholesterol diet (n¼5)
368.5874.97 362.6374.98
1.5070.14 7.9771.57*
1.1270.08 1.9470.20*
0.73570.13 2.0570.20*
2.9270.30 2.2870.32
1.7970.20 1.2670.14
1.1370.20 1.0270.18
61.4274.93% 56.4872.67%
7.3170.40% 9.3471.51%
12.1771.62 10.8371.39
Fig. 1. Arterial partial pressure of oxygen (PaO2) to fractional inspired oxygenation
(FiO2) ratio during the ventilation of rats fed a standard or high cholesterol diet
exposed to acid/air aspiration (A) high-tidal volume mechanical ventilation (B) and
whole lung lavage (C). #¼Po0.05 acid versus air, §¼Po0.05 versus time baseline
within group. HC-high cholesterol, Vt – Tidal Volume.
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Following instillation, rats were continued to be ventilated (Vt¼8 mL/
kg, RR¼54–58 bmp, PEEP¼5 cmH2O and FiO2¼1.0) for 120 min with
airway pressure, hemodynamics, and blood gas measurements
monitored and recorded every 15–30min.
2.2.2. High-tidal volume mechanical ventilation
A high-tidal volume mechanical ventilation model of VILI was
used as previously described [15]. After reaching BL inclusion
criteria, standard and high cholesterol diet animals were switched
from baseline ventilator settings to a high-stretch ventilation
strategy (Vt¼30 mL/kg, RR¼16–18 bmp, PEEP¼0 cmH2O,
FiO2¼1.0) and mechanically ventilated for 180 min [17,22]. Airway
pressure, hemodynamics, and blood gas measurements were
monitored every 15–30 min during ventilation.
2.2.3. Whole lung lavage model of lung injury
A third experimental model of surfactant depletion was utilized as
previously described [24]. Animals meeting the BL inclusion criteria
were disconnected from the ventilator and subjected to a whole lung
lavage using 10 mL saline via syringe attached to the endotracheal
tube. The peak inspiratory pressure (PIP) was measured prior to and
subsequently after lavage, and volume of saline administered and
recovered were recorded. After withdrawal of the lavage material, the
rat was re-attached to the ventilator and given a single breath hold
and a blood sample was taken. The lavage protocol was repeated a
minimum of four times (to a maximum of 6) until the inclusion cri-
teria of PaO2r250 mmHg and PIPr16 cmH2O were achieved. Rats
were then ventilated for an additional 120 min (Vt¼8mL/kg,
RR¼54–58 bmp, PEEP¼5 cmH2O and FiO2¼1.0) with monitoring as
described above.
2.3. Surfactant isolation, processing, and analysis
At the completion of ventilation, a blood sample was obtained to
verify serum cholesterol levels and animals were subsequently eu-
thanized with an IV overdose of sodium pentobarbital (110 mg/kg).
Animals were exsanguinated and a midline sternectomy was per-
formed. Lungs were lavaged previously described [17,22]. The lavage
samples were then centrifuged at 150xg for 10 min and supernatant
containing the total surfactant was aliquoted and stored at 20 °C.
An aliquot of the freshly isolated surfactant was centrifuged at
40,000xg for 15 min to separate the supernatant containing the SA
sub-fraction and the pellet containing LA. The pellet was re-sus-
pended in saline and both sub-fractions were stored at 20 °C. A
modiﬁed Duck-Chong phosphorous assay was performed on lipid
extracts from the LA and SA surfactant samples to determine the
phospholipid content [25,26]. Free cholesterol in LA samples was
determined by a Free Cholesterol-E kit according to the manufac-
turer's instructions (Wako Chemicals, Richmond, VA, USA).
Total protein in lavage samples were measured via micro BCA
protein assay according to the manufacturer's instructions (Pierce
Biotechnology, Rockford, IL, USA). IL-6 levels in lavage were mea-
sured using an enzyme-linked immunosorbent assay (ELISA) kit
(BD Biosciences, San Diego, Calif., USA), according to manufac-
turer's instructions.
2.4. Biophysical analysis
For analysis of isolated surfactant's surface tension reducing
ability, LA samples were re-suspended at a phospholipid con-
centration of 2 mg/mL in buffer containing 2.5 mM HEPES, 1.5 mM
CaCl2, and 140 mM NaCl, pH¼7.4. Samples were incubated at 37 °C
for at least 1 h prior to assessing the surface tension reducing
properties using a constrained sessile drop surfactometer (CSD) as
previously reported [27]. Brieﬂy, the system involved a pedestal,3 mm in diameter with a 1 mm pinhole, placed within a chamber
incubated at 37 °C. Approximately 9–10 mL of surfactant sample
was deposited onto the top of the pre-wet pedestal and allowed to
equilibrate for 3 min to allow surfactant adsorption. Following
equilibration, dynamic cycling was performed through repeated
Table 2
Physiology of rats that underwent one of three models of experimental lung injury.
Physiology parameter Peak inspiratory pressure (cmH2O) Heart rate (beats per min) Blood pressure (mmHg) PaCO2 in blood (mmHg)
Diet Standard HC Standard HC Standard HC Standard HC
Air control
Baseline–air 11.470.4 11.070.2 269713 26877 74.074.5 67.373.8 35.972.6 30.172.7
120 min–air 14.270.5§ 14.170.8§ 282713 30477 88.7713 76.5716.9 42.271.8 37.573.4
Acid aspiration
Baseline–acid 11.270.4 11.770.5 28378 265715 62.774.0 67.372.9 37.371.7 38.371.4
120 min–acid 17.470.5#,§ 18.671.6#,§ 283711 274715 63.974.6 65.8710.5 42.871.7 44.972.5
High tidal volume mechanical ventilation
Baseline–VILI 11.370.4 10.670.5 242711 283712 82.5718.0 79.377.0 34.872.2 38.073.0
180 min–VILI 31.872.9§ 31.472.2§ 27979 308721 39.377.0 27.877.8§ 43.2714.9 22.977.3
Lavage
Baseline –lavage 11.070.3 11/070.4 26078.6 25675.3 73.176.8 86.974.9 34.771.2 36.772.2
120 min –lavage 19.371.2§ 20.471.6§ 285710.2 26278.2 58.079.0§ 64.077.2§ 53.773.0§ 58.972.8§
PaCO2 – partial pressure carbon dioxide in arterial blood, HC – high cholesterol.
§ Po0.05 versus time baseline within treatment group.
# Po0.05 acid versus air instillation.
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puter controlled stepping motor (model LTA-HS actuator, Newport
Corporation, Irvine, CA) to control ﬂuid drop volume. Samples
underwent 20 compression/expansion cycles at a rate of 30 cycles
per minute during which images of the drop were taken at a rate
of 10 frames per second. Samples were consistently compressed to
72–78% of original area at each cycle. Axisymmetric Drop Shape
Analysis was used to determine sample area and surface tensions
of each picture taken during the dynamic compression-expansion
cycles.
2.5. Statistics
Data are expressed as means7standard error (SE). Differences
between diets in experimental groups measured over time was
done by a two-way repeated measures analysis of variance (AN-
OVA) with Bonferroni post-hoc test. An unpaired two-way stu-
dent's T-test was used to determine signiﬁcance for individual
time point comparisons between the two diets in the non-venti-
lated rats, the high tidal volume mechanical ventilation rats, and in
the surfactant depletion rats. For comparisons between air in-
stilled and acid instilled rats from either diet, a two-way ANOVA
followed by Bonferroni post-hoc test was used. All statistics were
performed using statistical analysis program GraphPad Prism
(GraphPad Software, La Jolla, CA, USA). Probability (p) values of
less than 0.05 were considered statistically signiﬁcant.3. Results
3.1. Baseline characteristics
Baseline characteristics including weights, serum cholesterol
proﬁle, and lavage surfactant characteristics of animals fed stan-
dard and high-cholesterol diet groups are shown in Table 1. A
signiﬁcant increase in total serum cholesterol, triglycerides, and
HDL levels were observed in animals consuming a high-choles-
terol diet. At baseline, lavage and surfactant composition including
cholesterol concentration within surfactant was not signiﬁcantly
different between the two diets groups.
3.2. Lung physiology: assessment of lung injury
The oxygenation responses of animals within the different ex-
perimental models of lung injury are depicted in Fig. 1. In the ﬁrst
model of injury, rats instilled with acid showed a rapid decrease inoxygenation that was signiﬁcantly different from baseline values
throughout the course of ventilation (Fig. 1(A)). Furthermore, the
PaO2:FiO2 values were signiﬁcantly lower in acid instilled rats
compared rats receiving air throughout the duration of mechanical
ventilation. No signiﬁcant differences in oxygenation in either acid
or air instilled animals were observed between standard or high-
cholesterol diet groups. Oxygenation response during 180 min of
high tidal volume mechanical ventilation is shown in Fig. 1(B).
Signiﬁcant decreases in blood oxygenation values compared to
baseline were observed from 150 min onwards in both diet
groups; however, there was no signiﬁcant difference between
animals fed a standard or high-cholesterol diet. Finally, in the
model of whole lung lavage, a signiﬁcant decrease in oxygenation
compared to baseline was observed following the lavage proce-
dure with no signiﬁcant differences observed between standard
and high-cholesterol diet groups (Fig. 1(C)).
Physiological measurements of injury from baseline and the
end of the ventilation period are shown in Table 2. Although
several signiﬁcant physiologic effects were observed in each of the
experimental injury groups comparing baseline values to those at
the end of ventilation, no signiﬁcant differences were observed
between standard and high-cholesterol diet fed animals in any of
the experimental models.
3.3. Surfactant analysis
Fig. 2 shows the amount of surfactant recovered from rat lungs
by lavage. There was no signiﬁcant difference in the amount of
functional LA (Fig. 2(A)) or inactive SA (Fig. 2(B)), recovered from
rats that received acid aspiration versus the air control. Moreover,
there was no difference observed between standard and high-
cholesterol diet animals with respect to each surfactant subtype
recovered in any of the three models of experimental lung injury.
Further comparisons of the LA as a percentage of total surfactant
(LA/LAþSA) recovered yielded no statistically signiﬁcant differ-
ences between rats that were exposed to either diet (Fig. 2(C)).
Quantiﬁcation of free cholesterol in the surfactant LA fraction is
shown in Fig. 3. Within each model of experimental lung injury
there was no difference in surfactant associated cholesterol be-
tween rats fed either diet. It was observed that only rats that were
subjected to high-tidal volume mechanical ventilation had ele-
vated levels of cholesterol in surfactant compared to baseline non
injured animals.
Table 3 shows values of total protein and IL-6 concentrations
measured in lavage ﬂuid isolated from each of the experimental
models of lung injury with comparisons made between the two
Fig. 2. Surfactant recovered via lavage from rats fed a standard or high cholesterol
diet and exposed to one of three models of experimental lung injury. Surfactant
recovered as large aggregates (A), small aggregates (B), and percent large ag-
gregates of total surfactant (C). No statistical signiﬁcance, P40.05. HC-high cho-
lesterol, Vt-Tidal Volume, LA-large aggregates, BW-body weight.
Fig. 3. Cholesterol content as a percentage of lavage LA phospholipids isolated
from rats fed a standard or a high cholesterol diet exposed to one of three models
of experimental lung injury. No statistical signiﬁcance, P40.05. HC-High choles-
terol, Vt-Tidal Volume.
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pillary permeability, while lavage IL-6 levels were utilized as a
marker of alveolar inﬂammation. In general, within each model of
lung injury, no differences were observed between standard and
high cholesterol diet animals with respect to lavage protein or IL-6
concentrations.
3.4. Surfactant biophysical function
Minimum surface tension achieved during compression of the
sample was used as the primary indicator of biophysical function.
Minimum surface tensions (mN/m) achieved at cycles 1, 5, 10, 15,20 are shown in Fig. 4. Firstly, rats that were fed a high cholesterol
diet trended to have higher minimum surface tensions achieved
compared to standard diet counterparts for respective acid or air
treatments, although this did not reach statistical signiﬁcance for
any cycle (Fig. 4(A)). Secondly, there was no difference in surface
tension reducing capabilities observed for rats exposed to high-
tidal volume mechanical ventilation fed either diet at any cycle
(Fig. 4(B)). Lastly, rats that were exposed to a whole lung lavage
had signiﬁcantly impaired surfactant surface tension reductions
when fed a high cholesterol diet compared to rats fed a standard
diet at later compression cycles (Fig. 4(C)).4. Discussion/conclusion
Prior studies have implicated an increase in surfactant-asso-
ciated cholesterol content as a key contributor to surfactant dys-
function in the context of lung injury [17,28]; however, the impact
of circulating serum cholesterol levels on surfactant composition
and potential downstream implications for lung injury were un-
known. It was therefore hypothesized that serum hypercholes-
terolemia would predispose a host to a relatively more severe lung
injury as a result of changes in the pulmonary surfactant system.
Our primary ﬁndings demonstrate that despite achieving a four-
fold increase in serum cholesterol through a high-cholesterol diet,
no statistically signiﬁcant differences were observed between hy-
per- and normocholesterolemic rats with respect to conventional
markers of lung injury including changes in PIP, PaO2, lavage
protein, and lavage IL-6 concentration across three different
models of ARDS. Furthermore, surfactant cholesterol levels and
surfactant pool sizes were not signiﬁcantly altered in rats fed a
standard or high cholesterol diets. Additionally there was no
functional difference in minimum surface tension achievement
observed in surfactant isolated from rats fed both diets in two of
the three experimental models of injury. Thus, it is concluded that
diet-induced serum hypercholesterolemia does not lead to a direct
increase in cholesterol content within extracellular pulmonary
surfactant, and does not predispose, nor contribute to the severity
of lung injury.
The ﬁrst observation made in the current study was that there
was no statistical difference between standard and high-choles-
terol diet in our baseline control rats with respect to cholesterol
content within surfactant. This ﬁnding was somewhat surprising
in light of an earlier study conducted by McCrae and colleagues
which examined the surfactant system from adolescent female
mice fed a high-cholesterol diet [29]. These mice had a signiﬁcant
Table 3
Protein and IL-6 concentration in lavage from rats exposed to three models of experimental lung injury.
Total protein (mg/kg BW) IL-6 (pg/mL)
Diet Standard HC Standard HC
Air control 14.671.6 16.073.3 457.4748.6 733.27121.0
Acid aspiration 71.474.5# 102.9717.1# 1605.57253.1# 1470.67282.3
High Vt 150.5741.5 196.6767.4 3149.37787.4 3579.271157
Lavage 34.577.9 45.178.3 2600.77283.9 2175.57244.7
HC – High Cholesterol, Vt – Tidal Volume.
# Po0.001 acid versus air aspiration.
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cholesterol in their surfactant without marked changes to their
lamellar body content or lipid droplets in the lipoﬁbroblast [29].
Furthermore, assessment of surfactant biophysical function using a
capillary surfactometer demonstrated decreased airway patency
and reduced surface ﬁlm activity in hypercholesterolemic mice.
Potential explanations for the observed differences between our
results and those of McCrae include species speciﬁc differences
(rats versus mice), sex differences (male versus female), and dif-
ferences in the duration of exposure of animals to a high-choles-
terol diet (14–20 days versus 16 weeks). Furthermore these ex-
perimental differences have to take the complexity of cholesterol
metabolism within the type II cell into consideration. In this re-
gard, future studies examining the consequences of acute and
chronic hypercholesterolemia across multiple species of both
sexes, with a more detailed focus on the intracellular cholesterol
metabolism, are warranted.
In order to thoroughly investigate the effects of a high choles-
terol diet we utilized three distinct experimental models of lung
injury [30]. Acid aspiration, reﬂecting gastric aspiration as it occurs
in patients, provided a clinically relevant model to assess the effect
of heightened serum cholesterol on lung injury. Pathophysiologi-
cally this injury develops due to a chemical burn and the asso-
ciated inﬂammation [31], and does not typically resolve sponta-
neously over the two hour ventilation period. We investigated VILI
using high tidal volume mechanical ventilation since our previous
studies had demonstrated signiﬁcantly elevated cholesterol levels
within the surfactant after exposure to this type of injury [17]. This
injury develops over a 3 h time period due to repeated over
stretching and collapse of the lung alveoli associated with the
ventilation strategy. Finally, in the whole lung lavage model of
surfactant depletion, the absence of extracellular surfactant is re-
sponsible for the development of lung injury [20] and the im-
mediate need for de novo synthesis and secretion of surfactant
following surfactant depletion would have provided the most
likely opportunity to observe diet induced changes in surfactant-
associated cholesterol content. Despite the differences in initiating
insults leading to injury, the various severity of lung injury, and
the physiological changes over time, all three models provide
consistent evidence in support of the conclusion that hypercho-
lesterolemia does not impact the cholesterol content of surfactant
or the severity of lung injury.
In spite of the absence of differences observed between stan-
dard and high-cholesterol fed animals with respect to lung injury
outcomes, it is notable that differences were observed among the
three different models of lung injury. Speciﬁcally, only the VILI
model led to increase in surfactant-associated cholesterol content
in the lavage as compared to the values observed in non-injured
animals. Given the consistency of this observation across this and
other reported studies [17,22,28], it is suggested that this choles-
terol effect is related to the damaging result of injurious me-
chanical ventilation speciﬁcally rather than simply a generic effect
of lung injury and associated inﬂammation. Mechanistically, VILI
appears to occur due to repeated collapse and overstretching ofthe alveoli and in vitro studies have demonstrated that over-
stretching of various lung cells, including the surfactant producing
alveolar type II cells, can lead to detrimental intracellular effects
[32–34]. The main focus of these studies has been on inﬂammation
but it is possible that stretch induces effects on cholesterol and
surfactant metabolism that occur within the type II cell. From a
clinical perspective, the ﬁnding that elevated surfactant choles-
terol is, potentially, a ventilation speciﬁc phenomenon, makes it
tempting to speculate that surfactant-associated cholesterol levels
may provide a valid biomarker for the damaging effects of me-
chanical ventilation.
Our data, demonstrating a lack of differences between our
standard and high-cholesterol fed animals has one further im-
plication related to the mechanism by which cholesterol increases
within surfactant; namely it suggest that the cholesterol does not
simply leak into the alveolar space from the serum. Thus surfac-
tant cholesterol metabolism is altered during VILI speciﬁcally and,
since our data excludes leak and serum cholesterol levels as having
a major inﬂuence on this ﬁnding, future studies are required to
investigate which mechanisms are involved. It is possible that
surfactant cholesterol is increased in VILI due to reduced clearance
by alveolar macrophages from the airspace. However, considering
that during normal clearance only 20–30% of cholesterol is re-
moved in 24 h [35], such a mechanism seems unlikely. A more
likely scenario is an alteration in intracellular metabolism of
cholesterol and surfactant within the alveolar type II cell. This
intracellular metabolism of cholesterol involves a variety of dif-
ferentially regulated proteins associated with import and transport
of cholesterol into the lamellar body [20,21] which may be altered
due to VILI. A speciﬁc focus for future studies may be proteins like
as NPC1, NPC2, and ABCA1 since these proteins are responsible for
cholesterol transport in the alveolar type II cell. Moreover,
knockout animals of these proteins produce elevated cholesterol
within intracellular surfactant and extracellular surfactant [36,37].
Of the various outcomes measured within our study, statistical
signiﬁcance between the two diets was only observed in mea-
surements of surface tension reducing properties of LA-surfactant
isolated from the lavage model with a similar trend being ob-
served in the acid aspiration group. Importantly, these differences
in biophysical function were evidently not of a magnitude that
induced differences in physiologic outcomes. It is speculated that
the high cholesterol diet may have had effects on the composition
of other surfactant components, such as relative amounts of
phospholipid species, which may have impacted surfactant func-
tion following injury. Previous studies, demonstrating signiﬁcant
changes to the pulmonary surfactant system following altered diet
[38,39], are consistent with such a mechanism.
Although we were successful in the development of hyperch-
olesterolemic rats due to a diet high in cholesterol, there is only
limited information available on the lungs response to such con-
dition. It is possible that the lungs respond to such a condition
through a compensatory mechanism involving lipid storage in
pulmonary lipoﬁbroblasts [29] with potential impact on surfactant
only in a more chronic condition. A limitation of our study
Fig. 4. Minimum surface tension (mN/m) achieved during compression cycles 1, 5,
10, 15, and 20 of surfactant isolated from rats by lavage and concentrated 2 mg/mL
phospholipid. Rats were fed a standard or high cholesterol diet and were then
exposed to acid/air aspiration (A), high-tidal volume mechanical ventilation (B), or
whole lung lavage (C).*¼Po0.05 high cholesterol versus standard diet. HC – high
cholesterol, Vt – Tidal volume.
S. Milos et al. / Biochemistry and Biophysics Reports 7 (2016) 180–187186therefore, was that the onset of their hypercholesterolemia was
acute and does not represent the human development of the
condition due to chronic ingestion of high-fat and high-cholesterol
foods. It should be noted however, that this short term model was
selected to avoid possible confounding variables such as obesity orcomorbid cardiovascular disease in longer term dietary models. A
second limitation inherent to the majority of experimental models
of lung injury is the acute, short term nature of the experimental
protocols in contrast to the prolonged course of lung injury and
mechanical ventilation which may occur over a time from of days
to weeks [4,40]. Therefore, the impact of hypercholesteremia
during such a prolonged period of ventilation requires further
investigation.
In summary, diet-induced serum hypercholesterolemia did not
predispose rats to the development of more severe lung injury, nor
did it affect their surfactant composition. Increases in surfactant
cholesterol levels were observed only with the use of high-tidal
volume mechanical ventilation leading to the suggestion that re-
peated collapse and over-distension of alveoli may be responsible
for increased cholesterol within the surfactant. These ﬁndings
provide further insight into the damaging effect of mechanical
ventilation and the potential use of surfactant-associated choles-
terol levels as a marker of ventilator-induced lung injury. Overall,
our data argues against hypercholesteremia as a predisposing
factor affecting surfactant associated cholesterol levels during in-
jury and the development of lung injury.Acknowledgements
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